Vet compounders: How has GFI 256 changed things?
Published October 2, 2024
Simply put, we want to know if you’ve been affected by recent FDA guidance on veterinary compounding.
APC News
Being a PFM just got better
Published September 27, 2024
APC is launching five new benefits for our Pharmacy-Facility members to help you and your business prosper.
What’s in your liability policy?
Published September 27, 2024
How good is your liability insurance? Do you know exactly what it covers (and how to check) so you aren’t in for a nasty surprise?
Thompson elected, Browning appointed
Published September 27, 2024
Two changes to boards of directors were made last week.
HIPAA, schmipaa — Lilly is at it again
Published September 20, 2024
Now Eli Lilly is trying to "convince" people who have used compounded versions of tirzepatide to share their confidential medical records with the company.
Settlement reached in Evexias suit against FDA
Published September 20, 2024
A settlement has been reached in a lawsuit brought by Evexias et al against FDA over the agency's 2023 addition of a number of substances to Category 2 of the 503A bulks list.
Rochefort receives Malmberg Award
Published September 20, 2024
David Rochefort of Revelation Pharma is this year's recipient of the George and Lucy Malmberg Compounding Advocacy Champion award — APC’s highest honor.
For they’re jolly good Fellows*
Published September 20, 2024
This year’s CCH featured the induction of seven new APC fellows.
Be fruitful and multiply … our messaging, that is
Published September 13, 2024
Even if you didn't attend Compounders on Capitol Hill, you can multiply the effect of those Hill visits.
APC supports upcoming DEA guidance on constructive transfer
Published September 13, 2024
Some good news: DEA is set to issue much-needed new guidance on constructive transfer.
503Bs: FDA has questions, and so do we (do you?)
Published September 13, 2024
FDA has requested comments on the challenges and opportunities faced by compounding outsourcing facilities.
Meet our compounding defenders, guardians and champions (Oh my!)
Published September 13, 2024
Here’s a big thank you to our Package Deal investors.
PCAC to discuss 503A bulks list substances
Published September 6, 2024
FDA’s Pharmacy Compounding Advisory Committee has announced that it will hold two meetings (!) between now and year-end to consider recommending several bulk drug substances to the 503A Bulks List.
Welcome, new PFMs!
Published September 6, 2024
We’ve added 31 Pharmacy-Facility Members since February!
Let’s talk about that Lilly announcement
Published August 30, 2024
There’s been plenty of coverage of Eli Lilly’s announcement this week that it will sell vials of Zepbound directly to consumers at a discount. But the company seems to have left out a few important caveats.
